Molecular approaches for designing antiviral and antitumor compounds.
D000818:Animals; D000970:Antineoplastic Agents / Q000138:chemical synthesis / Q000494:pharmacology; D000998:Antiviral Agents / Q000138:chemical synthesis / Q000494:pharmacology; D001665:Binding Sites; D002417:Cattle; D004247:DNA; D004269:DNA, Bacterial; D012321:DNA-Directed RNA Polymerases / Q000378:metabolism; D003630:Daunorubicin / Q000032:analysis / Q000138:chemical synthesis; D004926:Escherichia coli; D007962:Leukocytes / Q000187:drug effects / Q000378:metabolism; D008979:Moloney murine leukemia virus / Q000187:drug effects / Q000378:metabolism; D009691:Nucleic Acid Denaturation; D011758:Pyrroles / Q000494:pharmacology; D013053:Spectrophotometry; D013056:Spectrophotometry, Ultraviolet; D013302:Streptomyces; D013329:Structure-Activity Relationship; D013698:Templates, Genetic; D013950:Thymus Gland; D014158:Transcription, Genetic / Q000187:drug effects
D000970:Antineoplastic Agents; D000998:Antiviral Agents; D004269:DNA, Bacterial; D011758:Pyrroles; D004247:DNA; D012321:DNA-Directed RNA Polymerases; D003630:Daunorubicin